News

The job cuts are part of a restructuring plan the company is implementing in order to reduce its costs. Around 60 jobs will be axed, leaving a workforce

The agreement, which was signed in August last year, granted Pfizer an option to acquire an exclusive worldwide license, covering proprietary NicOx nitric oxide-donating compounds. The compounds are

Advancis’ adult and adolescent pivotal program began on October 15, 2004. Over the coming weeks, patients will complete their treatment and follow-up visits, and Advancis and its clinical

The phase II trial is investigating the efficacy and safety of Fentanyl Taifun for the treatment of breakthrough cancer pain, monitoring response at different Fentanyl doses. It is

Baraclude (entecavir) is indicated for the treatment of chronic hepatitis B infection in adults with evidence of active viral replication and either evidence of persistent elevations in serum

The bad news for Pfizer was that Ranbaxy has successfully invalidated all claims sought in defense of Pfizer’s Austrian patent covering atorvastatin calcium, the active ingredient in the

The National Institutes of Health (NIH) trial is designed to study antiretroviral therapy (ART) alone versus ART with a therapeutic HIV immunization, Remune, in recently HIV-infected people. The

Chroma will provide the targets and DPI will use its comprehensive compound collection and its proprietary discovery processes and data management tools to identify potential lead compounds or

The primary objective of the phase I clinical study was to evaluate the safety, tolerability and pharmacokinetics of SGS518. The study was conducted among healthy volunteers in two